IBDEI1MG ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27513,1,4,0)
 ;;=4^N03.6
 ;;^UTILITY(U,$J,358.3,27513,2)
 ;;=^5015527
 ;;^UTILITY(U,$J,358.3,27514,0)
 ;;=N03.7^^106^1363^12
 ;;^UTILITY(U,$J,358.3,27514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27514,1,3,0)
 ;;=3^Chr nephritic syndrome w/ diffuse crescentic glomrlneph
 ;;^UTILITY(U,$J,358.3,27514,1,4,0)
 ;;=4^N03.7
 ;;^UTILITY(U,$J,358.3,27514,2)
 ;;=^5015528
 ;;^UTILITY(U,$J,358.3,27515,0)
 ;;=N03.8^^106^1363^19
 ;;^UTILITY(U,$J,358.3,27515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27515,1,3,0)
 ;;=3^Chr nephritic syndrome w/ other morphologic changes
 ;;^UTILITY(U,$J,358.3,27515,1,4,0)
 ;;=4^N03.8
 ;;^UTILITY(U,$J,358.3,27515,2)
 ;;=^5015529
 ;;^UTILITY(U,$J,358.3,27516,0)
 ;;=N03.9^^106^1363^20
 ;;^UTILITY(U,$J,358.3,27516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27516,1,3,0)
 ;;=3^Chr nephritic syndrome w/ unsp morphologic changes
 ;;^UTILITY(U,$J,358.3,27516,1,4,0)
 ;;=4^N03.9
 ;;^UTILITY(U,$J,358.3,27516,2)
 ;;=^5015530
 ;;^UTILITY(U,$J,358.3,27517,0)
 ;;=N04.0^^106^1363^60
 ;;^UTILITY(U,$J,358.3,27517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27517,1,3,0)
 ;;=3^Nephrotic syndrome w/ minor glomerular abnormality
 ;;^UTILITY(U,$J,358.3,27517,1,4,0)
 ;;=4^N04.0
 ;;^UTILITY(U,$J,358.3,27517,2)
 ;;=^5015531
 ;;^UTILITY(U,$J,358.3,27518,0)
 ;;=N04.1^^106^1363^59
 ;;^UTILITY(U,$J,358.3,27518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27518,1,3,0)
 ;;=3^Nephrotic syndrome w/ focal & segmental glomerular lesions
 ;;^UTILITY(U,$J,358.3,27518,1,4,0)
 ;;=4^N04.1
 ;;^UTILITY(U,$J,358.3,27518,2)
 ;;=^5015532
 ;;^UTILITY(U,$J,358.3,27519,0)
 ;;=N04.2^^106^1363^56
 ;;^UTILITY(U,$J,358.3,27519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27519,1,3,0)
 ;;=3^Nephrotic syndrome w/ diffuse membranous glomerulonephritis
 ;;^UTILITY(U,$J,358.3,27519,1,4,0)
 ;;=4^N04.2
 ;;^UTILITY(U,$J,358.3,27519,2)
 ;;=^5015533
 ;;^UTILITY(U,$J,358.3,27520,0)
 ;;=N04.3^^106^1363^57
 ;;^UTILITY(U,$J,358.3,27520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27520,1,3,0)
 ;;=3^Nephrotic syndrome w/ diffuse mesangial prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,27520,1,4,0)
 ;;=4^N04.3
 ;;^UTILITY(U,$J,358.3,27520,2)
 ;;=^5015534
 ;;^UTILITY(U,$J,358.3,27521,0)
 ;;=N04.4^^106^1363^55
 ;;^UTILITY(U,$J,358.3,27521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27521,1,3,0)
 ;;=3^Nephrotic syndrome w/ diffuse endocaplry prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,27521,1,4,0)
 ;;=4^N04.4
 ;;^UTILITY(U,$J,358.3,27521,2)
 ;;=^5015535
 ;;^UTILITY(U,$J,358.3,27522,0)
 ;;=N04.5^^106^1363^58
 ;;^UTILITY(U,$J,358.3,27522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27522,1,3,0)
 ;;=3^Nephrotic syndrome w/ diffuse mesangiocapillary glomrlneph
 ;;^UTILITY(U,$J,358.3,27522,1,4,0)
 ;;=4^N04.5
 ;;^UTILITY(U,$J,358.3,27522,2)
 ;;=^5015536
 ;;^UTILITY(U,$J,358.3,27523,0)
 ;;=N04.6^^106^1363^53
 ;;^UTILITY(U,$J,358.3,27523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27523,1,3,0)
 ;;=3^Nephrotic syndrome w/ dense deposit disease
 ;;^UTILITY(U,$J,358.3,27523,1,4,0)
 ;;=4^N04.6
 ;;^UTILITY(U,$J,358.3,27523,2)
 ;;=^5015537
 ;;^UTILITY(U,$J,358.3,27524,0)
 ;;=N04.7^^106^1363^54
 ;;^UTILITY(U,$J,358.3,27524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27524,1,3,0)
 ;;=3^Nephrotic syndrome w/ diffuse crescentic glomerulonephritis
 ;;^UTILITY(U,$J,358.3,27524,1,4,0)
 ;;=4^N04.7
 ;;^UTILITY(U,$J,358.3,27524,2)
 ;;=^5015538
 ;;^UTILITY(U,$J,358.3,27525,0)
 ;;=N04.8^^106^1363^61
 ;;^UTILITY(U,$J,358.3,27525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27525,1,3,0)
 ;;=3^Nephrotic syndrome w/ other morphologic changes
